☆ 4.4 Article

Population-Based Survival Analysis of Stage IVB Small-Cell Neuroendocrine Carcinoma in Comparison to Major Histological Subtypes of Cervical Cancer

CURRENT ONCOLOGY (2023)

Related references

Note: Only part of the references are listed.

Review Oncology

Recent Advances in the Management of Small Cell Carcinoma of the Uterine Cervix

Ai Miyoshi et al.

Summary: Small cell neuroendocrine carcinoma of the cervix (SCNEC) is a rare and aggressive disease that requires effective treatment. Chemotherapy, particularly with the combination of etoposide and platinum, is the most commonly used regimen for SCNEC. However, there is a lack of clinical trials specifically dedicated to SCNEC, highlighting the need for further research in this area.

ANTICANCER RESEARCH (2023)

Add to Collection

Review Oncology

Recent Advances in Cervical Cancer Management: A Review on Novel Prognostic Factors in Primary and Recurrent Tumors

Angela Santoro et al.

Summary: The aim of this review is to analyze the most novel and relevant prognostic factors in primary and recurrent cervical cancer. The most relevant factors identified include tumor budding and cell nest size grading system, depth of stromal invasion, lympho-vascular space invasion, perineural invasion, tumor-free distance, and tumor-infiltrating lymphocytes. These factors can be included in the pathology report to aid future studies in understanding cervical cancer prognosis.

CANCERS (2023)

Add to Collection

Article Pathology

SATB2 is expressed in neuroendocrine carcinoma of the uterine cervix

Frediano Inzani et al.

Summary: The study demonstrated frequent expression of SATB2 in NECs of the uterine cervix, potentially aiding in assessing the origin of NECs.

VIRCHOWS ARCHIV (2022)

Add to Collection

Article Oncology

Genomic characterization of small cell carcinomas of the uterine cervix

Anne M. Schultheis et al.

Summary: The study found that uterine cervix SCCs have a low mutation burden and few copy number alterations, with the majority being HPV-positive, leading to inactivation of the suppressors p53 and RB, which differentiate them from SCLCs.

MOLECULAR ONCOLOGY (2022)

Add to Collection

Article Oncology

Definitive pelvic radiation therapy improves survival in stage IVB neuroendocrine cervical carcinoma: A NeCTuR study

Gloria Salvo et al.

Summary: This study evaluated the survival impact of adding definitive pelvic radiation therapy (RT) to chemotherapy in patients with stage IVB neuroendocrine cervical carcinoma (NECC). The results showed that adding RT to chemotherapy improved the progression-free survival (PFS) and overall survival (OS) of patients compared to chemotherapy alone. Therefore, pelvic RT may have a significant impact on the survival of patients with stage IVB NECC.

GYNECOLOGIC ONCOLOGY (2022)

Add to Collection

Review Oncology

Improving cervical cancer survival-A multifaceted strategy to sustain progress for this global problem

Stephanie Markovina et al.

Summary: Cervical cancer is characterized by significant socioeconomic and racial disparities in various aspects including incidence, mortality, morbidity, and years of life lost. The standard-of-care treatment for locally advanced cervical cancer has not seen significant innovation since 1999, and current chemoradiation therapy has a failure rate of 30%-50% with no cure for recurrent or metastatic disease. The National Institutes of Health recognizes the urgent need to address the global clinical problem of cervical cancer morbidity and mortality, and efforts are being made to advance research in this area. This review discusses the state of the science and opportunities for improving cervical cancer survival, with a focus on improving access, utilizing technology in innovative ways, and enhancing the current understanding of cervical cancer biology.

CANCER (2022)

Add to Collection

Article Obstetrics & Gynecology

Small cell neuroendocrine carcinoma of the cervix: Analysis of prognostic factors and patterns of metastasis

Sushmita Gordhandas et al.

Summary: This study describes the characteristics and outcomes of patients with small cell neuroendocrine carcinoma of the cervix (SCNCC) and determines that the International Federation of Gynecology and Obstetrics (FIGO) staging system is more predictive of outcome. The study suggests that providers should consider brain imaging for patients with SCNCC, particularly in the presence of visceral metastases.

GYNECOLOGIC ONCOLOGY REPORTS (2022)

Add to Collection

Article Oncology

The prognostic impact of the immune microenvironment in small-cell neuroendocrine carcinoma of the uterine cervix: PD-L1 and immune cell subtypes

Xiaoying Sun et al.

Summary: This study investigated the correlation between PD-L1 and TAIC density in small-cell neuroendocrine carcinoma of the uterine cervix. The results suggest that PD-L1 may work synergistically with other immune cells to support an adaptive immune response and PD-L1 positivity could be a favorable prognostic factor in SCNEC.

CANCER CELL INTERNATIONAL (2022)

Add to Collection

Article Obstetrics & Gynecology

Complete Response to Combination Nivolumab and Ipilimumab in Recurrent Neuroendocrine Carcinoma of the Cervix

Thomas A. Paterniti et al.

Summary: Small cell neuroendocrine carcinoma of the cervix is a rare and aggressive tumor, with poor survival rates. In a case study, a 52-year-old woman with recurrent disease achieved a complete and durable response after treatment with a combination of nivolumab and ipilimumab, suggesting that this treatment option may be promising for this type of cancer.

OBSTETRICS AND GYNECOLOGY (2021)

Add to Collection

Article Oncology

The next generation sequencing of cancer-related genes in small cell neuroendocrine carcinoma of the cervix

Xuan Pei et al.

Summary: Small cell neuroendocrine carcinoma of the cervix (SCNEC) is specifically associated with HPV 18 infection and characterized by a high genetic mutation rate, with mutations in genes related to the p53 pathway potentially affecting prognosis. Some patients harbor mutations in homogeneous recombination repair (HRR) genes, providing therapeutic targets. The study suggests that targeted therapies against certain mutated genes may have potential efficacy in SCNEC patients.

GYNECOLOGIC ONCOLOGY (2021)

Add to Collection

Article Oncology

PD-L1, Mismatch Repair Protein, and NTRK Immunohistochemical Expression in Cervical Small Cell Neuroendocrine Carcinoma

Longyun Chen et al.

Summary: The study suggests that PD-L1 may be an effective therapeutic target for cervical small cell neuroendocrine carcinoma, which is MMR-stable and lacks NTRK gene fusion. However, immunohistochemistry is not a reliable method for detecting NTRK gene fusion in this type of cancer.

FRONTIERS IN ONCOLOGY (2021)

Add to Collection

Article Medicine, General & Internal

Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer

N. Colombo et al.

Summary: Adding pembrolizumab to chemotherapy significantly improves progression-free and overall survival in patients with persistent, recurrent, or metastatic cervical cancer when compared to placebo. Anemia and neutropenia are the most common grade 3 to 5 adverse events.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Oncology

A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART SWOG 1609) in Patients with Nonpancreatic Neuroendocrine Tumors

Sandip P. Patel et al.

CLINICAL CANCER RESEARCH (2020)

Add to Collection

Article Oncology

Incorporation of whole pelvic radiation into treatment of stage IVB cervical cancer: A novel treatment strategy

Victoria Perkins et al.

GYNECOLOGIC ONCOLOGY (2020)

Add to Collection

Article Oncology

Evaluation of PARP and PDL-1 as potential therapeutic targets for women with high-grade neuroendocrine carcinomas of the cervix

Matthew Ryan Carroll et al.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2020)

Add to Collection

Article Cell Biology

PD-L1, RB1 and mismatch repair protein immunohistochemical expression in neuroendocrine carcinoma, small cell type, of the uterine cervix

Sarah Morgan et al.

HISTOPATHOLOGY (2019)

Add to Collection

Article Oncology

A multi-center retrospective study of neuroendocrine tumors of the uterine cervix: Prognosis according to the new 2018 staging system, comparing outcomes for different chemotherapeutic regimens and histopathological subtypes

Mitsuya Ishikawa et al.

GYNECOLOGIC ONCOLOGY (2019)

Add to Collection

Review Oncology

Neuroendocrine carcinoma of the cervix: a systematic review of the literature

Clemens B. Tempfer et al.

BMC CANCER (2018)

Add to Collection

Review Oncology

Small cell cancers of the female genital tract: Molecular and clinical aspects

Jay R. Patibandla et al.

GYNECOLOGIC ONCOLOGY (2018)

Add to Collection

Article Pathology

Introducing a novel highly prognostic grading scheme based on tumour budding and cell nest size for squamous cell carcinoma of the uterine cervix

Moritz Jesinghaus et al.

JOURNAL OF PATHOLOGY CLINICAL RESEARCH (2018)

Add to Collection

Article Oncology

Exceptional Response to Nivolumab and Stereotactic Body Radiation Therapy (SBRT) in Neuroendocrine Cervical Carcinoma with High Tumor Mutational Burden: Management Considerations from the Center For Personalized Cancer Therapy at UC San Diego Moores Cancer Center

Andrew Sharabi et al.

ONCOLOGIST (2017)

Add to Collection

Article Oncology

Natural history and outcome of neuroendocrine carcinoma of the cervix

Benjamin Margolis et al.

GYNECOLOGIC ONCOLOGY (2016)

Add to Collection

Article Oncology

Sequencing of mutational hotspots in cancer-related genes in small cell neuroendocrine cervical cancer

Michael Frumovitz et al.

GYNECOLOGIC ONCOLOGY (2016)

Add to Collection

Article Medicine, General & Internal

Improved Survival with Bevacizumab in Advanced Cervical Cancer

Krishnansu S. Tewari et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Add to Collection

Article Oncology

Diagnosis, clinicopathologic features, treatment, and prognosis of small cell carcinoma of the uterine cervix; Kansai Clinical Oncology Group/Intergroup study in Japan

Shiho Kuji et al.

GYNECOLOGIC ONCOLOGY (2013)

Add to Collection

Article Oncology

Primary treatment and prognostic factors of small cell neuroendocrine carcinoma of the uterine cervix: A Taiwanese Gynecologic Oncology Group study

Kung-Liahng Wang et al.

EUROPEAN JOURNAL OF CANCER (2012)

Add to Collection

Article Obstetrics & Gynecology

Incidence mortality, and prognostic factors of small cell carcinoma of the cervix

Jergin Chen et al.

OBSTETRICS AND GYNECOLOGY (2008)

Add to Collection

Article Oncology

Prognostic factors in neuroendocrine small cell cervical carcinoma - A multivariate analysis

JK Chan et al.

CANCER (2003)

Add to Collection

© Peeref 2019-2024. All rights reserved.